Ionis Pharmaceuticals (IONS) Earnings Date, Estimates & Call Transcripts → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free IONS Stock Alerts $40.93 -1.35 (-3.19%) (As of 05/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryLatest Earnings DateFeb. 21ConfirmedActual EPS (Feb. 21) -$0.06 Beat By $0.72 Consensus EPS (Feb. 21) -$0.78 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Ionis Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for IONS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIONS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IONS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. Ionis Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.85)($0.72)($0.80) Q2 20243($1.05)($0.82)($0.96) Q3 20243($1.04)($0.89)($0.97) Q4 20243($1.15)($0.58)($0.90) FY 202412($4.09)($3.01)($3.63) Q1 20251($1.13)($1.13)($1.13) Q2 20251($0.95)($0.95)($0.95) Q3 20251($0.93)($0.93)($0.93) IONS Earnings Date and InformationIonis Pharmaceuticals last posted its quarterly earnings data on February 21st, 2024. The reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.78) by $0.72. The company had revenue of $325 million for the quarter, compared to the consensus estimate of $176.01 million. Its revenue was up 113.8% on a year-over-year basis. Ionis Pharmaceuticals has generated ($2.56) earnings per share over the last year (($2.56) diluted earnings per share). Earnings for Ionis Pharmaceuticals are expected to grow in the coming year, from ($3.76) to ($3.22) per share. Read More Ionis Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/21/2024Q4 2023($0.78)($0.06)+$0.72($0.06)$176.01 million$325.00 million 11/2/2023Q3 2023($1.01)($1.03)($0.02)($1.03)$139.42 million$144.00 million8/9/2023Q2 2023($0.94)$0.60+$1.54$0.60$136.84 million$188.00 million 5/3/2023Q1 2023($1.00)($0.87)+$0.13($0.87)$126.88 million$131.00 million 2/22/2023Q4 2022($1.06)($0.37)+$0.69($0.37)$160.21 million$152.00 million 11/9/2022Q3 2022($0.74)($0.33)+$0.41($0.33)$149.48 million$160.00 million Get the Latest News and Ratings for IONS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ionis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($0.61)($0.74)($0.13)($0.74)$142.65 million$134.00 million 5/4/2022Q1 2022($0.68)($0.46)+$0.22($0.46)$122.46 million$142.00 million 2/24/2022Q4 2021$0.80$1.41+$0.61$1.41$284.08 million$440.00 million 11/3/2021Q3 2021($0.53)($0.58)($0.05)($0.58)$162.01 million$133.00 million 8/4/2021Q2 2021($0.56)($0.57)($0.01)($0.57)$128.46 million$126.00 million Ionis Pharmaceuticals Earnings - Frequently Asked Questions When did Ionis Pharmaceuticals announce their last quarterly earnings? Ionis Pharmaceuticals (NASDAQ:IONS) last announced its quarterly earning data on Wednesday, February 21, 2024. Learn more on IONS's earnings history. Did Ionis Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ionis Pharmaceuticals (NASDAQ:IONS) reported ($0.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.78) by $0.72. Learn more on analysts' earnings estimate vs. IONS's actual earnings. How can I listen to Ionis Pharmaceuticals's earnings conference call? The conference call for Ionis Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Ionis Pharmaceuticals's conference call transcript? The conference call transcript for Ionis Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Ionis Pharmaceuticals's earnings report? Ionis Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded annual revenue of $788 million. How much profit does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded net income of -$366.29 million. IONS has generated -$2.56 earnings per share over the last four quarters. What is Ionis Pharmaceuticals's EPS forecast for next year? Ionis Pharmaceuticals's earnings are expected to grow from ($3.76) per share to ($3.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ALKS Earnings Date MDGL Earnings Date FOLD Earnings Date GERN Earnings Date UTHR Earnings Date BMRN Earnings Date TEVA Earnings Date ALNY Earnings Date CYTK Earnings Date BPMC Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:IONS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
